作者
Wenzhi Pan,Daxin Zhou,Ziyad M. Hijazi,Shakeel Qureshi,Worakan Promphan,Yuan Feng,Gejun Zhang,Xianbao Liu,Xin Pan,Lianglong Chen,Qilin Cao,Koh Ghee Tiong,Ming Chern Leong,Supaporn Roymanee,Pimpak Prachasilchai,Jae Young Choi,Hideshi Tomita,Ju Le Tan,Khurram Akhtar,Simon Lam,Chak-Yu So,Do N. Tin,Lan Hieu Nguyen,Yong Huo,Jianan Wang,Junbo Ge
摘要
Abstract Transcatheter pulmonary valve replacement (TPVR), also known as percutaneous pulmonary valve implantation, refers to a minimally invasive technique that replaces the pulmonary valve by delivering an artificial pulmonary prosthesis through a catheter into the diseased pulmonary valve under the guidance of X‐ray and/or echocardiogram while the heart is still beating not arrested. In recent years, TPVR has achieved remarkable progress in device development, evidence‐based medicine proof and clinical experience. To update the knowledge of TPVR in a timely fashion, and according to the latest research and further facilitate the standardized and healthy development of TPVR in Asia, we have updated this consensus statement. After systematical review of the relevant literature with an in‐depth analysis of eight main issues, we finally established eight core viewpoints, including indication recommendation, device selection, perioperative evaluation, procedure precautions, and prevention and treatment of complications.